Skin, Melanoma- Biopsy, Excision, & Re

advertisement
MELANOMA OF THE SKIN: BIOPSY, EXCISION, RE-EXCISION CASE SUMMARY
MNEMONIC – MELANOMA12
MELANOMA OF THE SKIN: BIOPSY, EXCISION, RE-EXCISION CASE SUMMARY
PROCEDURE
Biopsy, shave
Biopsy, punch
Biopsy, incisional
Excision
Re-Excision
Lymphadenectomy, sentinel node(s)
Lymphadenectomy, regional nodes (specify):
Other (specify):
Not specified
SPECIMEN LATERALITY
Right
Left
Midline
Not specified
TUMOR SITE (required only if tumor is grossly evident):
Specify (if known):
Not specified
TUMOR SIZE
Greatest dimension: cm
Additional dimensions: x cm
Indeterminate (see comment)
MACROSCOPIC SATELLITE NODULE(S) (required for excision specimens only)
Not identified
Present
Indeterminate
MACROSCOPIC PIGMENTATION
Not identified
Present, diffuse
Present, patchy/focal
Indeterminate
HISTOLOGIC TYPE
Melanoma, not otherwise classified
Superficial spreading melanoma
Nodular melanoma
Lentigo maligna melanoma
Acral-lentiginous melanoma
Desmoplastic and/or desmoplastic neurotropic melanoma
Melanoma arising from blue nevus
Melanoma arising in a giant congenital nevus
Melanoma of childhood
Nevoid melanoma
Persistent melanoma
Other (specify):
MAXIMUM TUMOR THICKNESS
Specify: mm
At least
mm (see Comment)
Indeterminate (see Comment)
ANATOMIC LEVEL
I (Melanoma in situ)
II (Melanoma present in but does not fill and expand papillary dermis)
III (Melanoma fills and expands papillary dermis)
IV (Melanoma invades reticular dermis)
V (Melanoma invades subcutis)
ULCERATION
Present
Not identified
Indeterminate
MARGINS (select all that apply)
Peripheral Margins
Cannot be assessed
Uninvolved by invasive melanoma
Distance of invasive melanoma from closest peripheral margin: mm
(required for excisions only)
Specify location(s), if possible:
Involved by invasive melanoma
Specify location(s), if possible:
Uninvolved by melanoma in situ
Distance of melanoma in situ from closest margin: mm (required for excisions only)
Specify location(s), if possible:
Involved by melanoma in situ
Specify location(s), if possible:
Deep Margin
Cannot be assessed
Uninvolved by invasive melanoma
Distance of invasive melanoma from margin: mm
(required for excisions only)
Specify location(s), if possible:
Involved by invasive melanoma
Specify location(s), if possible:
MITOTIC RATE
None identified
>1/mm2 (specify number):
MICROSATELLITOSIS
Not identified
Present
Indeterminate
LYMPH-VASCULAR INVASION
Not identified
Present
Indeterminate
PERINEURAL INVASION
Not identified
Present
Indeterminate
TUMOR-INFILTRATING LYMPHOCYTES
Not identified
Present, nonbrisk
Present, brisk
TUMOR REGRESSION
Not identified
Present, involving < 75% of lesion
Present, involving 75% or more of lesion
Indeterminate
GROWTH PHASE
Radial
Vertical
Indeterminate
LYMPH NODES (REQUIRED ONLY IF LYMPH NODES ARE PRESENT IN THE
SPECIMEN)
Number of sentinel nodes examined:
Total number of nodes examined (sentinel and nonsentinel):
Number of lymph nodes with metastases:
Extranodal tumor extension:
Present
Not identified
Indeterminate
Size of largest metastatic focus: (mm) (for sentinel node)
Location of metastatic tumor (for sentinel node)
Subcapsular
Intramedullary
Subcapsular and intramedullary
PATHOLOGIC STAGING (pTNM)
m (multiple)
r (recurrent)
y (post-treatment)
PRIMARY TUMOR (pT)
pTX: Primary tumor cannot be assessed (eg, shave biopsy or regressed or curettaged
melanoma), (see Comment)
pTO: No evidence of primary tumor
pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I)
pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration
pT1a: Melanoma 1.0 mm or less in thickness , no ulceration < 1 mitoses/mm2
pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1 or more mitoses/mm2
pT2: Melanoma 1.01 to 2 mm in thickness, with or without ulceration
pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration
pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration
pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration
pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration
pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration
pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration
REGIONAL LYMPH NODES (pN)
No nodes submitted or found
pNX: Regional lymph nodes cannot be assessed
pNO: No regional lymph node metastasis
pN1: Metastasis in 1 regional lymph node
pN1a: Clinically occult (microscopic) metastasis
pN1b: Clinically apparent (macroscopic) metastasis
pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal
metastasis
pN2a: Clinically occult (microscopic) metastasis
pN2b: Clinically apparent (macroscopic) metastasis
pN2c: Satellite or in-transit metastasis without nodal metastasis
pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or in-transit
metastasis or satellite(s) with metastasis in regional node(s)
Number of lymph nodes identified:
Number containing metastases identified macroscopically:
Number containing metastases identified microscopically:
Matted nodes:
Present
Not identified
DISTANT METASTASIS (pM)
pMO: No detectable evidence of distant metastasis
pM1: Distant metastasis (documented in this specimen)
pM1a: Metastasis in skin, subcutaneous tissue, or distant lymph nodes
pM1b: Metastasis to lung
pM1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an
elevated serum lactic dehydrogenase (LDH)
Specify site, if known:
ADDITIONAL PATHOLOGIC FINDINGS
Nevus remnant
Other (specify):
Pathologic TNM (AJCC 7th Edition): pT N M
Download